Ensign Peak Advisors’s Immunovant IMVT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $454K | Hold |
28,406
| – | – | ﹤0.01% | 1582 |
|
|
2025
Q1 | $485K | Buy |
28,406
+8,700
| +44% | +$149K | ﹤0.01% | 1562 |
|
|
2024
Q4 | $488K | Sell |
19,706
-138,915
| -88% | -$3.44M | ﹤0.01% | 1602 |
|
|
2024
Q3 | $4.52M | Sell |
158,621
-45,600
| -22% | -$1.3M | 0.01% | 654 |
|
|
2024
Q2 | $5.39M | Buy |
204,221
+37,165
| +22% | +$981K | 0.01% | 604 |
|
|
2024
Q1 | $5.4M | Sell |
167,056
-994
| -0.6% | -$32.1K | 0.01% | 615 |
|
|
2023
Q4 | $7.08M | Buy |
168,050
+20,700
| +14% | +$872K | 0.01% | 536 |
|
|
2023
Q3 | $5.66M | Buy |
+147,350
| New | +$5.66M | 0.01% | 532 |
|
|
2022
Q4 | – | Sell |
-6,350
| Closed | -$35K | – | 1985 |
|
|
2022
Q3 | $35K | Buy |
6,350
+2,670
| +73% | +$14.7K | ﹤0.01% | 2264 |
|
|
2022
Q2 | $14K | Hold |
3,680
| – | – | ﹤0.01% | 2140 |
|
|
2022
Q1 | $20K | Hold |
3,680
| – | – | ﹤0.01% | 2180 |
|
|
2021
Q4 | $31K | Buy |
+3,680
| New | +$31K | ﹤0.01% | 2165 |
|